Menu

Microbiota Manipulations

Two research teams develop tools for tinkering with a bacterial genus prominent in human guts.

Jul 17, 2017
Ruth Williams

BUG CONTROL: Researchers modified an endogenous Bacteroides promoter sequence to be inducible—it can be turned on or off in mice by adding (right) or omitting (left)  anhydrotetracycline (aTC) to the animal’s drinking water. The aTC binds to the TET repressor protein (yellow), thereby preventing its suppression of gene expression. As a proof of principle, the researchers integrated the modified promoter upstream of a sialidase gene in the bacterium’s genome, and showed they could control the enzyme’s activity in mouse intestines.© GEORGE RETSECK

The past decade has seen a surge in microbiome research and, with it, a greater appreciation of the relationships between resident microbes and their hosts. But the focus is shifting, says microbiologist and immunologist Justin Sonnenburg of Stanford University. A major goal of the field, at least in terms of human research, he says, is “to leverage our gut microbes so they can perform tasks,” such as deliver drugs or take physiological measurements.

But engineering gut bacteria is not straightforward, primarily because researchers have relatively little experience with the species that live in and on our bodies, says gastroenterologist Suzanne Devkota of Cedars-Sinai Medical Center in Los Angeles. “There are 1,001 ways to genetically manipulate E. coli,” she says, “but that’s not particularly useful in the human context because [E. coli] is not a dominant member of our gut bacteria.”

Now, two independent research teams led by Sonnenburg and by Andrew Goodman of Yale University have created tools to manipulate Bacteroides species, which represent about half of the bacteria that make up the gut microbiome, and have shown that they work in mouse guts.

Goodman’s team modified an endogenous Bacteroides promoter sequence to be inducible—it could be turned on or off in mice by adding or omitting an effector molecule in the animals’ drinking water (see illustration). Sonnenburg’s system, on the other hand, used a viral promoter that upregulated gene expression to 70-fold higher than the type of promoter used by Goodman’s team. The viral promoter had the power to drive levels of fluorescent protein expression high enough to visualize bacteria in the mouse gut—a previously impossible feat. Unlike Goodman’s system, however, it was not inducible in vivo.

The two systems are “really quite complementary” says Devkota. Both provide “a way to gain insights into our native gut microbiota,” she adds, which “is a big step forward.” (Cell, 169:547-58, 2017; Cell, 169:538-46, 2017)  

BACTEROIDS GENE-EXPRESSION TOOLS SYSTEM COMPONENTS HOW IT WORKS GENE CONTROL APPLICATIONS
Goodman system (illustrated) Bacteroides 16S rRNA promoter modified to contain an anhydrotetracycline (aTC)-responsive TET operator element Inserting the modified promoter upstream of endogenous Bacteroides genes enables
inducible gene expression.
From fully off to fully on, with dose-dependent expression in between

Investigating the phenotypic effects of switching gut bacterial genes on or off
Future: Delivery of drugs or other factors with temporal control

Sonnenburg
system
A set of powerful promoter sequences adapted from a bacteriophage promoter and fluorescent protein coding sequences Constructs containing the
promoters and fluorescent
proteins are integrated into Bacteroides genomes. Each species produces a different fluorescent hue for identification.
A set of promoters drives
a range of bacterial
expression levels up to extremely high levels.

 
Distinguishing and localizing specific Bacteroides species in the gut
Future: Delivery of drugs, or other factors needed at high doses

 

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.